LAUSANNE, Switzerland--(BUSINESS WIRE)--Saphetor SA today announce that it is partnering with world-leading healthcare intelligence and clinical research organisation ICON to develop an innovative ...

Suzanne Jansen, MSc, PharmD, ICON, says early-phase clinical success depends on flexible, simple formulations that support wide dose ranges, matching placebos, and robust stability. Formulations are ...

The inherent variability and potential inaccuracies of AI-generated output can leave even experienced clinicians uncertain about AI recommendations. This dilemma is not novel; it mirrors the broader ...